Agios Pharmaceuticals Inc ROCE
What is the ROCE of Agios Pharmaceuticals Inc?
The ROCE of Agios Pharmaceuticals Inc is -51.37%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with roce similar to Agios Pharmaceuticals Inc
- Calamp has ROCE of -51.80%
- Outset Medical has ROCE of -51.66%
- MOGU Inc has ROCE of -51.57%
- Optimum Ventures has ROCE of -51.50%
- ProPhase Labs Inc has ROCE of -51.46%
- Cutera Inc has ROCE of -51.42%
- Agios Pharmaceuticals Inc has ROCE of -51.37%
- InMed Pharmaceuticals has ROCE of -51.35%
- Tubi has ROCE of -51.30%
- Spartan Acquisition has ROCE of -51.28%
- Iovance Biotherapeutics Inc has ROCE of -51.23%
- Foremost Ventures has ROCE of -51.23%
- ADC Therapeutics SA has ROCE of -51.14%